Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation

• Published in: Carcinogenesis (New York) 2017-07, Vol.38 (7), p.708-716
• Main Authors: Dabbah, Mahmoud, Attar-Schneider, Oshrat, Tartakover Matalon, Shelly, Shefler, Irit, Jarchwsky Dolberg, Osnat, Lishner, Michael, Drucker, Liat
• Format: Article
• Language: English
• Subjects: Autophagy - genetics; Bone Marrow Cells - metabolism; Bone Marrow Cells - pathology; Cell Line, Tumor; Cell Proliferation - genetics; Cell-Derived Microparticles - metabolism; Cell-Derived Microparticles - pathology; Flow Cytometry; Humans; Mesenchymal Stromal Cells - metabolism; Mesenchymal Stromal Cells - pathology; Multiple Myeloma - genetics; Multiple Myeloma - metabolism; Multiple Myeloma - pathology; Protein Biosynthesis; Signal Transduction - genetics
• ISSN: 0143-3334; 1460-2180
• DOI: 10.1093/carcin/bgx045

Multiple myeloma (MM) cells' interaction with the bone marrow (BM) microenvironment critically hinders disease therapy. Previously, we showed that MM co-culture with BM-mesenchymal stem cells (MSCs) caused co-modulation of translation initiation (TI) and cell phenotype and implicated secreted components, specifically microvesicles (MVs). Here, we studied the role of the BM-MSCs [normal donors (ND) and MM] secreted MVs in design of MM cells' phenotype, TI and signaling. BM-MSCs' MVs collected from BM-MSCs (MM/ND) cultures were applied to MM cell lines. After MVs uptake confirmation, the MM cells were assayed for viability, cell count and death, proliferation, migration, invasion, autophagy, TI status (factors, regulators, targets) and MAPKs activation. The interdependence of MAPKs, TI and autophagy was determined (inhibitors). ND-MSCs MVs' treated MM cells demonstrated a rapid (5 min) activation of MAPKs followed by a persistent decrease (1-24 h), while MM-MSCs MVs' treated cells demonstrated a rapid and continued (5 min-24 h) activation of MAPKs and TI (↑25-200%, P < 0.05). Within 24 h, BM-MSCs MVs were internalized by MM cells evoking opposite responses according to MVs origin. ND-MSCs' MVs decreased viability, proliferation, migration and TI (↓15-80%; P < 0.05), whereas MM-MSCs' MVs increased them (↑10-250%, P < 0.05). Inhibition of MAPKs in MM-MSCs MVs treated MM cells decreased TI and inhibition of autophagy elevated cell death. These data demonstrate that BM-MSCs MVs have a fundamental effect on MM cells phenotype in accordance with normal or pathological source implemented via TI modulation. Future studies will aim to elucidate the involvement of MVs-MM receptor ligand interactions and cargo transfer in our model.